Active Substance/INN | Bortezomib |
---|---|
Dosage | 2.5 mg/ml |
Pharmaceutical Form | Injectable solution |
Product Type |
Bortezomib EVER Pharma (Bortezomib)
Pharmacotherapeutic Group: Oncology
Biojam Area: Biojam Pharma Portugal
Related products
Vascular
Parkinson's disease
Rare Diseases
Oncology